RYTHMOL labels and packages

Revision as of 01:22, 13 March 2014 by ShiSheng (talk | contribs) (Created page with "__NOTOC__ {{Propafenone}} {{CMG}}; {{AE}} {{SS}} ==Dosage Forms and Strengths== {| |thumb|600px |} {| |thumb|600px |}<ref n...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Propafenone
RYTHMOL® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Labels and Packages
RYTHMOL SR® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Labels and Packages
Clinical Trials on Propafenone
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Dosage Forms and Strengths



[1]

References

  1. ↑ "RYTHMOL (PROPAFENONE HYDROCHLORIDE) TABLET, FILM COATED [GLAXOSMITHKLINE LLC]". Retrieved 12 March 2014.
Retrieved from "https://www.wikidoc.org/index.php?title=RYTHMOL_labels_and_packages&oldid=954992"